SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 09, 2007. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a). It does not contain general business updates or operational results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly limited to reporting specific share transactions by an executive.
Material Changes
No material changes to the company's financial position or operations are reported. The only change noted is the personal shareholding activity of Mr. R Bondy.
Management Commentary and Risks
There is no management commentary, guidance, outlook, or discussion of risks and contingencies in this filing. The document contains no unusual items related to corporate performance.
Key Facts for Investor Verification
- Executive Transaction: Mr. R Bondy exercised options on 10,515 Ordinary shares on August 09, 2007.
- Option Details: Options were granted on November 13, 1997, under the SmithKline Beecham Employee Share Option Plan 1991, with an exercise price of GBP 12.28 per share.
- Share Sale: Immediately following the exercise, 10,515 Ordinary shares were sold on August 09, 2007, at a price of GBP 12.94 per share.
- Reporting Date: The company was advised of these transactions on August 09, 2007.